Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$19.40 +0.41 (+2.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Change in Accured Expenses (2013 - 2026)

Updated

Viridian Therapeutics, Inc.\DE (VRDN) reported Change in Accured Expenses of $6.11 million for Q2 2026, down 1.1% from $6.18 million a year earlier.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Change in Accured Expenses (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Viridian Therapeutics, Inc.\DE's Change in Accured Expenses came in at $8.36 million, up 67.8% year-over-year; for FY2025, it came in at $16.21 million, down 24.0% from FY2024.

  • Change in Accured Expenses has a five-year compound annual growth rate of 26.5% (FY2020 to FY2025).
  • By year, Change in Accured Expenses came in at $21.34 million in FY2024 (+351.9%), $4.72 million in FY2023 (-38.8%), $7.72 million in FY2022 (+459.1%) and $1.38 million in FY2021 (-72.5%).
  • Five-year quarterly Change in Accured Expenses spans a low of -$23.69 million in Q1 2026 and a high of $21.32 million in Q4 2025.
  • Year over year, Change in Accured Expenses gained in three of the last five quarters, with growth averaging 46.9%.
  • The high point for year-over-year Change in Accured Expenses in five years was Q1 2023 (growth of 433.3%); the low point was Q1 2022 (a decline of 84.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$23.69 million (Q1 2026), $21.32 million (Q4 2025) and $4.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Viridian Therapeutics, Inc.\DE 2.20 Bn 2.20 Bn - 6.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.11 Mn
Mar 31, 2026 -23.69 Mn
Dec 31, 2025 21.32 Mn
Sep 30, 2025 4.61 Mn
Jun 30, 2025 6.18 Mn
Mar 31, 2025 -15.91 Mn
Dec 31, 2024 10.79 Mn
Sep 30, 2024 3.91 Mn
Jun 30, 2024 7.53 Mn
Mar 31, 2024 -894,000.00
Dec 31, 2023 4.53 Mn
Sep 30, 2023 -5.03 Mn
Jun 30, 2023 2.64 Mn
Mar 31, 2023 2.58 Mn
Dec 31, 2022 6.00 Mn
Sep 30, 2022 -4.25 Mn
Jun 30, 2022 5.48 Mn
Mar 31, 2022 483,000.00
Dec 31, 2021 1.63 Mn
Sep 30, 2021 -5.93 Mn
API Access

Viridian Therapeutics, Inc.\DE Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VRDN&period=max&api_key=YOUR_API_KEY